Method of treating osteoarthritis with human oncostatin M antibodies
US10941197B2 · kind B2 · utility
0Cited by
23References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2018 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Mar 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.